Astrazeneca (AZN) Debt Ratio (2009 - 2026)

Astrazeneca (AZN) has reported Debt Ratio for 18 consecutive years, with 0.21 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt Ratio rose 14.62% year-over-year to 0.21; the TTM figure through Mar 2026 stood at 0.21 (up 14.62% YoY), while the FY2025 annual figure was 0.19, down 168.33% from the prior year.
• Debt Ratio came in at 0.21 for Q1 2026 at Astrazeneca, down from 0.19 in the prior quarter.
• The five-year high for Debt Ratio was 87.84 in Q4 2023, with the low at 0.28 in Q1 2022.
• Average Debt Ratio over 5 years is 5.0, with a median of 0.24 recorded in 2022.
• Across the five-year window, Debt Ratio soared 29869.56% in 2023 and sank 168.33% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.29 in 2022, then jumped by 29869.56% to 87.84 in 2023, then slumped by 99.68% to 0.28 in 2024, then tumbled by 168.33% to 0.19 in 2025, then declined by 13.21% to 0.21 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.21, 0.19, and 0.22 for Q1 2026, Q4 2025, and Q3 2025 respectively.